We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTEA
11801
CALL
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$103K ﹤0.01%
36,500
+18,800
+106% +$57.8K
MCAE
11802
DELISTED
Mountain Crest Acquisition Corp. III Common Stock
MCAE
$103K ﹤0.01%
+10,435
New +$103K
RJA
11803
CALL
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Agriculture Total Return
RJA
$103K ﹤0.01%
+10,200
New +$96.9K
JUN.U
11804
DELISTED
Juniper II Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant
JUN.U
$103K ﹤0.01%
10,140
-61
-0.6% -$617
FRMM
11805
CALL
Forum Markets
FRMM
$77.3M
$102K ﹤0.01%
10
-11
-52% -$126K
BRFS
11806
PUT
DELISTED
BRF SA
BRFS
$102K ﹤0.01%
25,800
+3,700
+17% +$13.7K
ENSC icon
11807
CALL
Ensysce Biosciences
ENSC
$7.78M
$102K ﹤0.01%
+25
New +$165K
IMCC
11808
IM Cannabis
IMCC
$2.06M
$102K ﹤0.01%
26
-12
-32% -$49.1K
INFU icon
11809
PUT
InfuSystem Holdings
INFU
$240M
$102K ﹤0.01%
10,400
-2,700
-21% -$34.7K
LFST icon
11810
CALL
Lifestance Health
LFST
$4.7B
$102K ﹤0.01%
10,100
-14,300
-59% -$126K
IMDX
11811
CALL
Insight Molecular Diagnostics
IMDX
$135M
$102K ﹤0.01%
3,410
-1,295
-28% -$41.4K
PPBT
11812
PUT
Purple Biotech
PPBT
$2.73M
$102K ﹤0.01%
129
-12
-9% -$7.74K
OLOX
11813
CALL
Olenox Industries
OLOX
$1.81M
$102K ﹤0.01%
9
+7
+350% +$80.9K
CDAK
11814
PUT
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$102K ﹤0.01%
16,300
+4,600
+39% +$28.9K
FVT
11815
DELISTED
Fortress Value Acquisition Corp. III
FVT
$102K ﹤0.01%
10,360
-16,882
-62% -$165K
ATRS
11816
PUT
DELISTED
Antares Pharma, Inc.
ATRS
$102K ﹤0.01%
24,800
-9,400
-27% -$34.1K
EPM icon
11817
Evolution Petroleum
EPM
$131M
$101K ﹤0.01%
+14,914
New +$95.9K
HIPO icon
11818
PUT
Hippo Holdings
HIPO
$876M
$101K ﹤0.01%
2,036
-6,480
-76% -$335K
KEP icon
11819
Korea Electric Power
KEP
$15B
$101K ﹤0.01%
+10,827
New +$100K
RCMT icon
11820
CALL
RCM Technologies
RCMT
$298M
$101K ﹤0.01%
+10,200
New +$73.3K
SVRA icon
11821
Savara
SVRA
$1.08B
$101K ﹤0.01%
77,233
+66,470
+618% +$80.1K
VNRX icon
11822
PUT
VolitionRx Ltd
VNRX
$6.48M
$101K ﹤0.01%
1,675
-290
-15% -$16.4K
ORKA
11823
PUT
Oruka Therapeutics
ORKA
$6.03B
$101K ﹤0.01%
3,642
-83
-2% -$2.06K
DXYN
11824
CALL
DELISTED
Dixie Group Inc
DXYN
$101K ﹤0.01%
32,500
-24,300
-43% -$101K
AERI
11825
DELISTED
Aerie Pharmaceuticals
AERI
$101K ﹤0.01%
+11,137
New +$85.8K

Similar funds

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.